[HTML][HTML] European consensus-based interdisciplinary guideline for melanoma. Part 2: treatment-update 2022
A unique collaboration of multidisciplinary experts from the European Dermatology Forum
(EDF), the European Association of Dermato-Oncology (EADO), and the European …
(EDF), the European Association of Dermato-Oncology (EADO), and the European …
Imiquimod in dermatology: an overview
E Hanna, R Abadi, O Abbas - International journal of …, 2016 - Wiley Online Library
Imiquimod is an immune response modifier commercially available as a 3.75 and 5% cream.
Topical imiquimod stimulates the innate and adaptive immune responses and induces …
Topical imiquimod stimulates the innate and adaptive immune responses and induces …
[HTML][HTML] Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
This ESMO Clinical Practice Guidelines provide updated recommendations on management
of cutaneous melanoma (diagnosis, treatment and follow-up), compiled by a …
of cutaneous melanoma (diagnosis, treatment and follow-up), compiled by a …
Guidelines of care for the management of primary cutaneous melanoma
SM Swetter, H Tsao, CK Bichakjian… - Journal of the American …, 2019 - Elsevier
The incidence of primary cutaneous melanoma continues to increase each year. Melanoma
accounts for the majority of skin cancer–related deaths, but treatment is usually curative …
accounts for the majority of skin cancer–related deaths, but treatment is usually curative …
[HTML][HTML] European consensus-based interdisciplinary guideline for melanoma. Part 2: treatment–update 2019
A unique collaboration of multidisciplinary experts from the European Dermatology Forum,
the European Association of Dermato-Oncology and the European Organization for …
the European Association of Dermato-Oncology and the European Organization for …
Guidelines of care for the management of primary cutaneous melanoma
CK Bichakjian, AC Halpern, TM Johnson… - Journal of the American …, 2011 - Elsevier
The incidence of primary cutaneous melanoma has been increasing dramatically for several
decades. Melanoma accounts for the majority of skin cancer–related deaths, but treatment is …
decades. Melanoma accounts for the majority of skin cancer–related deaths, but treatment is …
[HTML][HTML] The snowballing literature on imiquimod-induced skin inflammation in mice: a critical appraisal
Since 2009, the imiquimod-or Aldara-induced (3M Pharmaceuticals, St. Paul, MN) model of
acute skin inflammation has become the most widely used mouse model in preclinical …
acute skin inflammation has become the most widely used mouse model in preclinical …
Outcomes of melanoma in situ treated with Mohs micrographic surgery compared with wide local excision
A Nosrati, JG Berliner, S Goel, J McGuire… - JAMA …, 2017 - jamanetwork.com
Importance Melanoma in situ (MIS) is increasing in incidence, and expert consensus opinion
recommends surgical excision for therapeutic management. Currently, wide local excision …
recommends surgical excision for therapeutic management. Currently, wide local excision …
Improved overall survival of melanoma of the head and neck treated with Mohs micrographic surgery versus wide local excision
J Hanson, A Demer, W Liszewski, N Foman… - Journal of the American …, 2020 - Elsevier
Background Optimal surgical management for melanoma of the head and neck remains
controversial. Objective Assess outcomes for melanomas of the head and neck treated with …
controversial. Objective Assess outcomes for melanomas of the head and neck treated with …
[HTML][HTML] Amelanotic Melanoma—Biochemical and Molecular Induction Pathways
P Misiąg, K Molik, M Kisielewska, P Typek… - International Journal of …, 2024 - mdpi.com
Amelanotic melanoma (AM) is a subtype of hypomelanotic or completely amelanotic
melanoma. AM is a rare subtype of melanoma that exhibits a higher recurrence rate and …
melanoma. AM is a rare subtype of melanoma that exhibits a higher recurrence rate and …